Skyrizi 600 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQQ7F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,348
Award facts
- Contract value 100% obligated
- $19,347.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,347.63 to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Skyrizi 600 mg/10 ml vials. The contract, which is firm fixed price and non-competitive set-aside, has an ultimate completion date of December 16, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's competitively awarded contracts with the DLA demonstrate its capability to fulfill federal medical supply requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and the U.S. Coast Guard. This particular delivery order for Skyrizi, a specialty pharmaceutical used in dermatological treatment, reflects the company's ongoing role as a primary supplier within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FQQ7F?
SPE2DR26FQQ7F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FQQ7F worth?
The government has obligated $19,348 on SPE2DR26FQQ7F.
Is contract SPE2DR26FQQ7F an order under another contract?
Yes. SPE2DR26FQQ7F is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ7F competed?
The extent of competition for SPE2DR26FQQ7F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award